4.8 Article

TRIM8 modulates the EWS/FLI oncoprotein to promote survival in Ewing sarcoma

Related references

Note: Only part of the references are listed.
Article Oncology

STAG2 mutations alter CTCF-anchored loop extrusion, reduce cis-regulatory interactions and EWSR1-FLI1 activity in Ewing sarcoma

Didier Surdez et al.

Summary: The study reveals that STAG2-LOF fine-tunes the activity of an oncogenic transcription factor by altering anchored CTCF loop extrusion and enhancer mechanisms, thereby affecting the invasive behavior of Ewing sarcoma cells.

CANCER CELL (2021)

Article Cell Biology

RAD21 is a driver of chromosome 8 gain in Ewing sarcoma to mitigate replication stress

Xiaofeng A. Su et al.

Summary: This study investigates the reason for chromosome 8 gains in 50% of Ewing sarcomas, finding that trisomy 8 mitigates replication stress induced by EWS-FLI1 through gaining a copy of RAD21. RAD21 promotes tumorigenesis through single gene copy gain, potentially explaining some recurrent aneuploidies in cancer.

GENES & DEVELOPMENT (2021)

Article Genetics & Heredity

A first-generation pediatric cancer dependency map

Neekesh Dharia et al.

Summary: A pediatric cancer dependency map was created using genome-scale CRISPR-Cas9 loss-of-function screens in 82 pediatric cancer cell lines, revealing genetic dependencies across various tumor types. Contrary to the belief that pediatric cancers have fewer mutations, it was found that genetic dependencies in pediatric cancer cell lines are similarly complex as in adult models, indicating new therapeutic targets for childhood cancers.

NATURE GENETICS (2021)

Article Oncology

STAG2 loss rewires oncogenic and developmental programs to promote metastasis in Ewing sarcoma

Biniam Adane et al.

Summary: The study shows that mutations in STAG2 can alter chromatin architecture and transcriptional programs, leading to a more aggressive cancer phenotype.

CANCER CELL (2021)

Article Multidisciplinary Sciences

Rapid and direct control of target protein levels with VHL-recruiting dTAG molecules

Behnam Nabet et al.

NATURE COMMUNICATIONS (2020)

Article Biochemistry & Molecular Biology

Covalent Ligand Screening Uncovers a RNF4 E3 Ligase Recruiter for Targeted Protein Degradation Applications

Carl C. Ward et al.

ACS CHEMICAL BIOLOGY (2019)

Article Multidisciplinary Sciences

Prioritization of cancer therapeutic targets using CRISPR-Cas9 screens

Fiona M. Behan et al.

NATURE (2019)

Article Biochemistry & Molecular Biology

Harnessing the anti-cancer natural product nimbolide for targeted protein degradation

Jessica N. Spradlin et al.

NATURE CHEMICAL BIOLOGY (2019)

Article Biochemistry & Molecular Biology

Electrophilic PROTACs that degrade nuclear proteins by engaging DCAF16

Xiaoyu Zhang et al.

NATURE CHEMICAL BIOLOGY (2019)

Article Multidisciplinary Sciences

TRIM8 is required for virus-induced IFN response in human plasmacytoid dendritic cells

Ghizlane Maarifi et al.

SCIENCE ADVANCES (2019)

Article Biochemistry & Molecular Biology

The dTAG system for immediate and target-specific protein degradation

Behnam Nabet et al.

NATURE CHEMICAL BIOLOGY (2018)

Article Biochemistry & Molecular Biology

Functional TRIM24 degrader via conjugation of ineffectual bromodomain and VHL ligands

Lara N. Gechijian et al.

NATURE CHEMICAL BIOLOGY (2018)

Article Cell Biology

Transcriptional Dysregulation of MYC Reveals Common Enhancer-Docking Mechanism

Jurian Schuijers et al.

CELL REPORTS (2018)

Review Oncology

NTRK fusion-positive cancers and TRK inhibitor therapy

Emiliano Cocco et al.

NATURE REVIEWS CLINICAL ONCOLOGY (2018)

Article Biochemistry & Molecular Biology

Cancer-Specific Retargeting of BAF Complexes by a Prion-like Domain

Gaylor Boulay et al.

Article Biochemistry & Molecular Biology

Defining a Cancer Dependency Map

Aviad Tsherniak et al.

Article Biochemical Research Methods

MultiQC: summarize analysis results for multiple tools and samples in a single report

Philip Ewels et al.

BIOINFORMATICS (2016)

Article Biochemistry & Molecular Biology

Proteasomal Degradation of the EWS-FLI1 Fusion Protein Is Regulated by a Single Lysine Residue

Maria E. Gierisch et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2016)

Article Biotechnology & Applied Microbiology

Optimized sgRNA design to maximize activity and minimize off-target effects of CRISPR-Cas9

John G. Doench et al.

NATURE BIOTECHNOLOGY (2016)

Article Biochemistry & Molecular Biology

Characterization of RA839, a Noncovalent Small Molecule Binder to Keapl and Selective Activator of Nrf2 Signaling

Angelika F. Winkel et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2015)

Article Biochemistry & Molecular Biology

limma powers differential expression analyses for RNA-sequencing and microarray studies

Matthew E. Ritchie et al.

NUCLEIC ACIDS RESEARCH (2015)

Letter Biochemical Research Methods

Improved vectors and genome-wide libraries for CRISPR screening

Neville E. Sanjana et al.

NATURE METHODS (2014)

Letter Medicine, General & Internal

Ceritinib in ALK-Rearranged Non-Small-Cell Lung Cancer REPLY

Alice T. Shaw et al.

NEW ENGLAND JOURNAL OF MEDICINE (2014)

Article Multidisciplinary Sciences

Lenalidomide Causes Selective Degradation of IKZF1 and IKZF3 in Multiple Myeloma Cells

Jan Kroenke et al.

SCIENCE (2014)

Article Oncology

The Genomic Landscape of Pediatric Ewing Sarcoma

Brian D. Crompton et al.

CANCER DISCOVERY (2014)

Article Medicine, Research & Experimental

MYC and the Control of Apoptosis

Steven B. McMahon

COLD SPRING HARBOR PERSPECTIVES IN MEDICINE (2014)

Article Biotechnology & Applied Microbiology

Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2

Michael I. Love et al.

GENOME BIOLOGY (2014)

Article Medicine, General & Internal

Ceritinib in ALK-Rearranged Non-Small-Cell Lung Cancer

Alice T. Shaw et al.

NEW ENGLAND JOURNAL OF MEDICINE (2014)

Article Biochemical Research Methods

STAR: ultrafast universal RNA-seq aligner

Alexander Dobin et al.

BIOINFORMATICS (2013)

Article Medicine, General & Internal

Retinoic Acid and Arsenic Trioxide for Acute Promyelocytic Leukemia

F. Lo-Coco et al.

NEW ENGLAND JOURNAL OF MEDICINE (2013)

Article Oncology

PARP-1 Inhibition as a Targeted Strategy to Treat Ewing's Sarcoma

J. Chad Brenner et al.

CANCER RESEARCH (2012)

Article Biotechnology & Applied Microbiology

clusterProfiler: an R Package for Comparing Biological Themes Among Gene Clusters

Guangchuang Yu et al.

OMICS-A JOURNAL OF INTEGRATIVE BIOLOGY (2012)

Article Multidisciplinary Sciences

Tripartite motif 8 (TRIM8) modulates TNFα- and IL-1β-triggered NF-κB activation by targeting TAK1 for K63-linked polyubiquitination

Qi Li et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)

Article Cell Biology

TRIM8 modulates STAT3 activity through negative regulation of PIAS3

Fumihiko Okumura et al.

JOURNAL OF CELL SCIENCE (2010)

Article Biochemistry & Molecular Biology

Efficient protection and isolation of ubiquitylated proteins using tandem ubiquitin-binding entities

Roland Hjerpe et al.

EMBO REPORTS (2009)

Article Pharmacology & Pharmacy

Small-Molecule Inhibitors of the MDM2-p53 Protein-Protein Interaction to Reactivate p53 Function: A Novel Approach for Cancer Therapy

Sanjeev Shangary et al.

Annual Review of Pharmacology and Toxicology (2008)

Article Multidisciplinary Sciences

Multiple aromatic side chains within a disordered structure are critical for transcription and transforming activity of EWS family oncoproteins

King Pan Ng et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)

Review Oncology

The impact of translocations and gene fusions on cancer causation

Felix Mitelman et al.

NATURE REVIEWS CANCER (2007)

Article Multidisciplinary Sciences

Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles

A Subramanian et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)

Article Biochemistry & Molecular Biology

Recombinant EWS-FLI1 oncoprotein activates transcription

A Üren et al.

BIOCHEMISTRY (2004)

Article Medicine, General & Internal

Hematologic and cytogenetic responses to imatinib mesylate in chronic myelogenous leukemia.

H Kantarjian et al.

NEW ENGLAND JOURNAL OF MEDICINE (2002)